Drug delivery is a term that refers to the delivery of a pharmaceutical compound into the body. Most common methods of delivery include the preferred non-invasive oral (through the mouth), nasal, pneumonial (inhalation), and rectal routes. Much research is now focussing on nanotechnology as a drug delivery method.
Treatment options for liver cancer are often limited and almost exclusively involve transplantation if possible, or local chemoembolization and radiofrequency ablation.
Researchers at Eindhoven University of Technology present a new method that should enable controlled drug delivery into the bloodstream using DNA computers.
Lipid nanoparticles (SLNs and NLCs) are regarded as highly promising systems for delivering nucleic acids in gene therapy.
Developing medications for children can be challenging—taste and texture are important, but safety is also a major concern, according to pharmaceutical sciences professor Om Perumal at South Dakota State University.
A research team led by scientists from Brigham and Women's Hospital and the Massachusetts Institute of Technology has developed a set of ingestible devices that draw energy from fluids in the stomach and the small intestine, and can provide power for nearly a week.
Evidence supporting a key role for an altered gut microbiome in the development of atopic dermatitis would suggest that the use of probiotics or prebiotics to correct microbial imbalances in the gut could help prevent or treat AD.
Polyhedral boranes, or clusters of boron atoms bound to hydrogen atoms, are transforming the biomedical industry
Chemists at Carnegie Mellon University have demonstrated that synthetic nanoparticles can achieve the same level of structural complexity, hierarchy and accuracy as their natural counterparts - biomolecules.
‘Last mile’ transportation and subsequent user storage conditions present unique challenges when it comes to ensuring the safe and effective use of pharmaceutical products. Berlinger & Co. AG, a market leader in pharmaceutical temperature monitoring, has released a White Paper entitled “Beyond the Cold Chain” that discusses the temperature-related problems associated with the delivery and storage of drugs after they leave the primary supply chain.
A pioneering IV administration set that allows clinicians to access a variety of pumps and deliver fluids in a safe manner will be launched at Arab Health 2017 by UK manufacturer, Mediplus.
Renishaw’s novel drug delivery system, to be used in partnership with Herantis Pharma Plc’s drug candidate CDNF for the treatment of Parkinson’s disease, is about to enter phase 1-2 clinical trials. The study will be supported by a €6 million grant from Horizon 2020, the European Union’s Framework Programme for Research and Innovation.
January is Glaucoma Awareness Month. The National Eye Institute, part of NIH, is highlighting key facts about this blinding disease, important tips for prevention and treatment, and research updates you may not know about.
A team of researchers led by Biomedical Engineering Professor Columbia Engineering has developed a way to manufacture microscale-sized machines from biomaterials that can safely be implanted in the body.
A chance meeting between a spider expert and a chemist has led to the development of antibiotic synthetic spider silk.
Scientists at the University of North Carolina at Chapel Hill have developed a breakthrough technique that uses light to activate a drug stored in circulating red blood cells so that it is released exactly when and where it is needed.
A study published today offers a new understanding of the complex cellular machinery that animal and fungi cells use to ensure normal cell division, and scientists say it could one day lead to new treatment approaches for certain types of cancers.
Many groups are working to discover new, safer ways to deliver drugs that fight cancer to the tumor without damaging healthy cells.
Most ophthalmic diseases are usually treated with topically administered drug formulations (e.g. eye drops).
The International Neuromodulation Society journal Neuromodulation: Technology at the Neural Interface is publishing expert, evidence-based guidance on the safe and efficient use of neuromodulation implants in patient-centered therapy.
Slayback Pharma LLC is pleased to announce the launch of Generic Zovirax Ointment (Acyclovir Ointment) 5%, by its out-licensee - Sandoz (Fougera). Slayback had developed the product and out-licensed the sales and marketing rights to Sandoz.